Lorazepam
- Product NDC
- 62135-861
- 11-digit product format
- 621350861
- Labeler code
- 62135
- Product ID
- 62135-861_26588a04-2ea3-599b-e063-6394a90aa2a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA071591
- Marketing category
- ANDA
- Marketing start
- 1987-10-13
- Substance
- LORAZEPAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lorazepam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LORAZEPAM | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O26FZP769L |
| Rxcui | 197900, 197901, 197902 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-861-01 | Lorazepam | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-861 | LORAZEPAM TABLET [CHARTWELL RX, LLC] | 1 | Current NDC, 1 package rows | 20241109_6b0619c5-b9e9-47e7-97b5-7e581e67cf5f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-861-01 | 62135086101 | 100 TABLET in 1 BOTTLE (62135-861-01) | 100 tablet | 2024-11-06 | No | No | Current |